[Add on lamivudine to adefovir monotherapy for the treatment of lamivudine-resistant chronic hepatitis B patients].
暂无分享,去创建一个
Young Ju Cho | S. Jeon | S. Lim | J. Cheong | S. Cho | Yoonchul Lee | M. Lee | C. Kang
[1] R. D. de Man,et al. On‐treatment monitoring of adefovir therapy in chronic hepatitis B: virologic response can be assessed at 24 weeks , 2009, Journal of viral hepatitis.
[2] J. Cheong,et al. Emergence of adefovir‐resistant mutants after reversion to YMDD wild‐type in lamivudine‐resistant patients receiving adefovir monotherapy , 2009, Journal of gastroenterology and hepatology.
[3] Yoshiyuki Suzuki,et al. Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: two-year follow-up. , 2008, Journal of hepatology.
[4] G. Barbarini,et al. Adefovir and lamivudine in combination compared with adefovir monotherapy in HBeAg-negative adults with chronic hepatitis B virus infection and clinical or virologic resistance to lamivudine: a retrospective, multicenter, nonrandomized, open-label study. , 2008, Clinical therapeutics.
[5] P. Lampertico,et al. Low resistance to adefovir combined with lamivudine: a 3-year study of 145 lamivudine-resistant hepatitis B patients. , 2007, Gastroenterology.
[6] M. Buti,et al. Viral genotype and baseline load predict the response to adefovir treatment in lamivudine-resistant chronic hepatitis B patients. , 2007, Journal of hepatology.
[7] Yoshiyuki Suzuki,et al. Factors associated with the virological response of lamivudine-resistant hepatitis B virus during combination therapy with adefovir dipivoxil plus lamivudine , 2007, Journal of Gastroenterology.
[8] S. Hadziyannis,et al. Adding‐on versus switching‐to adefovir therapy in lamivudine‐resistant HBeAg‐negative chronic hepatitis B , 2007, Hepatology.
[9] M. Yuen,et al. Adefovir Dipivoxil Monotherapy and Combination Therapy with Lamivudine for the Treatment of Chronic Hepatitis B in an Asian Population , 2007, Antiviral therapy.
[10] S. Yu,et al. Resistance to adefovir dipivoxil in lamivudine resistant chronic hepatitis B patients treated with adefovir dipivoxil , 2006, Gut.
[11] P. Marcellin,et al. P.102 Long-term adefovir dipivoxil treatment induces regression of liver fibrosis in patients with HBeAg-negative chronic hepatitis B: results after 5 years of therapy , 2006 .
[12] Ching-lung Lai,et al. Four years of lamivudine treatment in Chinese patients with chronic hepatitis B , 2004, Journal of gastroenterology and hepatology.
[13] N. Kim,et al. Detection of hepatitis B virus YMDD variants using mass spectrometric analysis of oligonucleotide fragments. , 2004, Journal of hepatology.
[14] R. Rubin,et al. Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B. , 2004, Gastroenterology.
[15] Ching-Lung Lai,et al. Long-term safety of lamivudine treatment in patients with chronic hepatitis B. , 2003, Gastroenterology.
[16] Ching-Lung Lai,et al. Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] B. McMahon,et al. Chronic hepatitis B , 2001, Hepatology.
[18] S. Hadziyannis,et al. Efficacy of long‐term lamivudine monotherapy in patients with hepatitis B e antigen–negative chronic hepatitis B , 2000, Hepatology.
[19] A. Lok,et al. Long-term follow-up of chronic hepatitis B patients treated with interferon alfa. , 1993, Gastroenterology.
[20] A. Detsky,et al. Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B , 1993, Annals of Internal Medicine.
[21] R. Perrillo. Treatment of Chronic Hepatitis B with Interferon: Experience in Western Countries , 1989, Seminars in liver disease.